Keynote speakers

Invited speakers

  • J. Attwater (MRC, Cambridge, UK) Emergence of cooperativity during in vitro selection of a self-synthesising ribozyme
  • F. Bouhedda (Univ Strasbourg, France) Evolution of efficient RNA-based fluorescent probes using ultrahigh- throughput functional screening
  • D. Brennan (McMaster Univ, Hamilton, Canada) A DNAzyme-based Colorimetric Paper Sensor for Helicobacter pylori
  • L. Choulier (Univ Strasbourg, France) RNA aptamers targeting integrin α5β1 as probes for cyto- and histo-fluorescence in glioblastoma
  • V. De Franciscis (CNR, Italy) Aptamers for the selective targeting of therapeutic RNAs
  • F. Ducongé (CEA, France) How to redirect molecular evolution when it goes in the wrong direction
  • M. Hernández-Jiménez (Apta Targets, Spain) ApTOLL, filling the gap of therapeutic molecules in ischemic stroke treatment
  • P. Giangrande (U. Iowa and Moderna, USA) Inhalation of an RNA Bio-drug Targeting Extracellular Histones Protects from Acute Lung Injury
  • L. Gold and N. Janjic (SomaLogic, USA) SOMAmers and SOMAscan: Molecular Snuggling and Binding Specificity
  • Valérie Guieu (Univ Grenoble-Alpes, France) Single-Stranded DNA Binding Protein-Assisted Fluorescence Polarization Aptamer Assay: generalization to an unstructured aptamer
  • P. M. Jurek (Pure Biologics, Poland) Development and characterization of a chemically modified DNA aptamer against a T-cell exhaustion marker using the PureAptaTM platform
  • N. Kacherovsky (U. Washington, USA) Traceless aptamer-mediated isolation of CD8+ T cells for CAR T cell therapy
  • V. Lucarelli (U. Auckland, New Zealand) Development of a novel aptamer-based biosensor to detect invasive mammal pests

  • P. R. Mallikaratchy (Lehman College, USA) Integrating ligand receptor interactions and in vitro evolution for streamlined discovery of artificial nucleic acid ligands against T-Cell receptor-CD3 Complex in human T-cells
  • G. Mayer (U. Bonn, Germany) Optoribogenetics to control cellular process
  • B. Olave (Univ Basque Country, Donostia-San Sebastian, Spain) First DNA-aptamers specific to non-physiological media. A SELEX towards ATP in ionic liquid
  • C. K. O’Sullivan (Univ Rovira I Virgili, Tarragona, Spain) One-pot SELEX: simultaneous selection of specific aptamers against diverse steroid targets
  • F. Pastor (Univ Navarra, Pampelona, Spain) ICOS costimulation at the tumor site in combination with CTLA-4 blockade therapy elicits antitumor immune responses
  • D. Rana (U. Twente, The Nethelands) Towards Controlling Vascularization within Engineered Tissues via Programmable Hydrogels
  • I. Rusinek (Augmanity, Israel) De novo discovery of tumoricidal aptamers in a DNA sequencing chip
  • B. Suess (U. Darmstadt, Germany) A TetR-binding aptamer as versatile regulatory element
  • B. Sullenger (U. Durham, USA) Targeting Blood Clots in vivo with Aptamers
  • M. Sunbul (Heidelberg Univ, Germany) Genetically Encoded Light-up Aptamers for Live-cell Super-resolution RNA Imaging
  • J.A. Tanner (U. Hong-Kong, China) Evolution, Crystal Structure, and Application of Cubane-Modified Aptamers – “Cubamers” – for Malaria Diagnosis
  • J.-J. Toulmé (Univ Bordeaux and Novaptech, France) Light-up aptaswitches for the detection of small molecules
  • Josef Wachtveitl (Goethe Univ, Frankfurt, Germany) Structure guided fluorescence labeling reveals a two-step binding mechanism of neomycin to its RNA aptamer